Wellness Study

Phase 4

• Conditions: Chronic illness - patients who are generally unwell for an extended period.; Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)

• Registration Number: ACTRN12608000398303
• Lead Sponsor: Mood Research Foundation (WA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-08-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Chronic illness - patients who are generally unwell for an extended period.

Exclusion Criteria

Patients with Malignancy or taking any prescribed antidepressant and/or pyschotrophic medication will be excluded from the trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in fatigue assessed by Fatigue Assessment Scale.[Screening and 6 weeks];Reduction in anxiety assessed by Spielberger Questionnaire and Hospital Anxiety and Depression (HAD) Scale.[Baseline, screening and 6 weeks]

Secondary Outcome Measures

Name	Time	Method
Increase in effort tolerance as assessed by the Medical Research Council (MRC) Dyspnoea Scale.[Baseline, screening and 6 weeks]